![Colorectal Cancer Alliance Announces 2022 Research Funding Opportunities](/sites/default/files/styles/1025x570/public/media/images/article/2022-colorectal-cancer-research-funding-opportunities-header.png.webp?itok=KGSPiAtN)
Colorectal Cancer Alliance Announces 2022 Research Funding Opportunities
![Colorectal Cancer Alliance Announces 2022 Research Funding Opportunities](/sites/default/files/styles/1025x570/public/media/images/article/2022-colorectal-cancer-research-funding-opportunities-header.png.webp?itok=KGSPiAtN)
The National Nonprofit Seeks Proposals for Early Career Investigator and Pilot Awards with High Potential to Improve Colorectal Cancer Diagnosis, Treatment, and Survivorship
The national nonprofit Colorectal Cancer Alliance (Alliance) today announced a Request for Proposals (RFP) for innovative translational research. The Alliance plans to award 7 two-year grants totaling $850,000.
In this cycle, proposals will be accepted for Early Career Investigator Awards and Pilot Awards to support the training of committed CRC researchers and foster innovation. Of particular interest are proposals that address these areas of critical interest:
- Understanding the causes and improving interventions in young-onset CRC
- The prognostic and therapeutic value of the microbiome
- Development of combination therapies
- Understanding the causes and interventions for racial and ethnic disparities in CRC
Early Career Investigator applicants must submit an eligibility checklist by June 9. Full proposals for both mechanisms are due July 25.
"The Alliance believes in our path to ending colorectal cancer in our lifetime and is committed to investing in innovation," said Andrea Goodman, Senior Vice President of Patient Support and Research Strategy. "We are proud to fund translational research across the scientific continuum and according to our Research Investment Strategy to thwart this disease that is too often neglected and stigmatized."
The Alliance has already invested nearly $5 million in colorectal cancer research, including nearly $3 million as early-stage grants to innovative researchers. Highlighting the return on its investments, two grantees with early-stage funding from the Alliance have gone on to receive more than $6.5 million in federal research funding to expand their projects.
Colorectal cancer remains the second deadliest cancer in the U.S. While novel treatments, advancements in screening, and a focus on equity are improving survivorship, there is still a tremendous unmet need. Federal funding for colorectal cancer research still lags behind funding for other diseases, with no real change in government funding between 2006 and 2018. The Alliance has committed to investing $30 million over the next five years in innovative research.
About the Colorectal Cancer Alliance
The Colorectal Cancer Alliance is a national nonprofit committed to ending colorectal cancer. Working with our nation of passionate allies, we diligently support the needs of patients and families, caregivers, and survivors; eagerly raise awareness of preventative screening; and continually strive to fund critical research. As allies in the struggle, we are fiercely determined to end colorectal cancer within our lifetime. For more information, please visit colorectalcancer.org.
Top resources
![The United States Capitol Building in Washington, D.C.](/sites/default/files/styles/450x250/public/media/images/us-capitol_0.png.webp?itok=dbbF7yeZ)
Alliance supports the Clinical Trials Modernization Act
This bipartisan legislation aims to improve participation in clinical trials by addressing major barriers such as non-medical expenses, trial location accessibility, diverse participation, and financial implications for patients.
![23andMe and Colorectal Cancer Alliance logos](/sites/default/files/styles/450x250/public/media/images/23andme-colorectalcanceralliance-light-blue.png.webp?itok=aQs0x-cp)
23andMe and the Alliance team up on cancer research
The collaboration aims to raise awareness, encourage screening, and help people better understand their risks.
![23andMe and Colorectal Cancer Alliance logos](/sites/default/files/styles/450x250/public/media/images/23andme-colorectalcanceralliance.png.webp?itok=GigcGZdo)
The Alliance and 23andMe Collaborate to Help Advance CRC Research in the Black Community
With 23andMe, the Alliance seeks another avenue to educate Black communities about the importance of knowing their family health history and risk factors to prevent colorectal cancer or find it at an early stage when it is most treatable.